All Stories

  1. Environmental pharmacology—Dosing the environment: IUPHAR review 36
  2. Community guidelines for GPCR ligand bias: IUPHAR review 32
  3. The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials
  4. International Union of Basic and Clinical Pharmacology. Guidelines for GPCR ligand bias
  5. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
  6. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
  7. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
  8. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
  9. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels
  10. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors
  11. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters
  12. Class A Orphans in GtoPdb v.2021.3
  13. Coronavirus (CoV) proteins in GtoPdb v.2021.3
  14. Endocannabinoid turnover in GtoPdb v.2021.3
  15. Carnitine palmitoyltransferase 1C negatively regulates the endocannabinoid hydrolase ABHD6 in mice, depending on nutritional status
  16. Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database
  17. Coronavirus (CoV) proteins (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database
  18. A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development. IUPHAR Review 29
  19. Barriers to the wider adoption of medicinal Cannabis
  20. SARS-CoV-2 proteins (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database
  21. A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology : Reproducibility of natural product research
  22. The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology
  23. Hydrolases (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
  24. Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
  25. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors
  26. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
  27. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
  28. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
  29. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
  30. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Nuclear hormone receptors
  31. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters
  32. The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
  33. Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
  34. Endocannabinoid turnover (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
  35. GPR18, GPR55 and GPR119 (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
  36. Hydrolases (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
  37. S33: Prolyl aminopeptidase (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
  38. Endocannabinoid system imbalance in the postmortem prefrontal cortex of subjects with schizophrenia
  39. Cannabinoids and their actions: An update
  40. Ligand discrimination during virtual screening of the CB1 cannabinoid receptor crystal structures following cross-docking and microsecond molecular dynamics simulations
  41. n−3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids
  42. Coronary artery hypoxic vasorelaxation is augmented by perivascular adipose tissue through a mechanism involving hydrogen sulphide and cystathionine-β-synthase
  43. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
  44. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
  45. Cannabinoid ligands, receptors and enzymes: Pharmacological tools and therapeutic potential
  46. Effects of the cannabinoid CB 1 agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
  47. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Catalytic receptors
  48. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Other ion channels
  49. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
  50. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters
  51. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
  52. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels
  53. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors
  54. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels
  55. Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts
  56. A critical role for cystathionine-β-synthase in hydrogen sulfide-mediated hypoxic relaxation of the coronary artery
  57. OUP accepted manuscript
  58. Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia
  59. Effects of hydrogen sulphide in smooth muscle
  60. Therapeutic potential of cannabis-related drugs
  61. The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors
  62. A focus on the enzymes for which there is pharmacological or therapeutic interest
  63. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
  64. The Concise Guide to PHARMACOLOGY 2015/16: Ligand-gated ion channels
  65. The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors
  66. The Concise Guide to PHARMACOLOGY 2015/16: Other ion channels
  67. The Concise Guide to PHARMACOLOGY 2015/16: Transporters
  68. The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels
  69. The Concise Guide to PHARMACOLOGY 2015/16: Overview
  70. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
  71. Erratum
  72. Experimental design and analysis and their reporting: new guidance for publication in BJP
  73. BJP is linking its articles to the IUPHAR/BPS Guide to PHARMACOLOGY
  74. Perivascular adipose tissue derived hydrogen sulphide contributes to hypoxic relaxation of the porcine coronary artery
  75. Effects of pro-inflammatory cytokines on cannabinoid CB1and CB2receptors in immune cells
  76. A potential role for cannabinoid receptors in the therapeutic action of fenofibrate
  77. A role for the sodium pump in H2O2-induced vasorelaxation in porcine isolated coronary arteries
  78. Effects of NAD at purine receptors in isolated blood vessels
  79. The endocannabinoid system is altered in the post‐mortem prefrontal cortex of alcoholic subjects
  80. Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation
  81. Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of ‘schizophrenia-like’ behaviour in the rat
  82. The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes
  83. The Concise Guide to PHARMACOLOGY 2013/14: Overview
  84. The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors
  85. The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
  86. The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels
  87. The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
  88. The Concise Guide to PHARMACOLOGY 2013/14: Transporters
  89. The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors
  90. The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels
  91. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
  92. Distinct mechanisms of relaxation to bioactive components from chamomile species in porcine isolated blood vessels
  93. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
  94. Hydrogen sulphide‐induced relaxation of porcine peripheral bronchioles
  95. Antagonism of P2Y1-induced vasorelaxation by acyl CoA: a critical role for palmitate and 3′-phosphate
  96. A Biophysical Model of Endocannabinoid-Mediated Short Term Depression in Hippocampal Inhibition
  97. 2012 cannabinoid themed section
  98. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat
  99. ENDOCANNABINOID TOXICITY IN A CELL CULTURE MODEL OF PARKINSON'S DISEASE
  100. GuideToPharmacology.org - an update
  101. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system
  102. Simvastatin evokes an unpredicted inhibition of β-adrenoceptor-mediated vasodilatation in porcine coronary artery
  103. Cannabinoid research in the 2010s
  104. So what do we call GPR18 now?
  105. Hydrogen peroxide as a mediator of vasorelaxation evoked by N-oleoylethanolamine and anandamide in rat small mesenteric arteries
  106. Oleamide activates peroxisome proliferator-activated receptor gamma (PPARγ) in vitro
  107. New updated GRAC Fifth Edition with searchable online version Launch of new portal Guide to Pharmacology in association with NC-IUPHAR Transporter-Themed Issue
  108. Transporters are an under-developed therapeutic target. Discuss
  109. Guide to Receptors and Channels (GRAC), 5th edition
  110. Consultants
  111. ENZYMES
  112. NUCLEAR RECEPTORS
  113. CATALYTIC RECEPTORS
  114. G PROTEIN-COUPLED RECEPTORS
  115. TRANSPORTERS
  116. ION CHANNELS
  117. LIGAND-GATED ION CHANNELS
  118. Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices
  119. The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans
  120. Second annual UK Purine Club Symposium report 2010
  121. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain
  122. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
  123. Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity
  124. EDITORIAL
  125. Effect of inhibition of extracellular signal-regulated kinase on relaxations to β-adrenoceptor agonists in porcine isolated blood vessels
  126. Guide to Receptors and Channels (GRAC), 4th edition
  127. Cannabinoids and their actions
  128. Evidence for the Expression of Multiple Uracil Nucleotide-Stimulated P2 Receptors Coupled to Smooth Muscle Contraction in Porcine Isolated Arteries
  129. The complications of promiscuity: endocannabinoid action and metabolism
  130. Minocycline Treatment Inhibits Microglial Activation and Alters Spinal Levels of Endocannabinoids in a Rat Model of Neuropathic Pain
  131. The Life Cycle of the Endocannabinoids: Formation and Inactivation
  132. Distribution and function of monoacylglycerol lipase in the gastrointestinal tract
  133. Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain
  134. Guide to Receptors and Channels (GRAC), 3rd edition
  135. Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death
  136. Cannabinoid activation of PPARα; a novel neuroprotective mechanism
  137. Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells
  138. Response to: "Relative importance of mechanisms needs clarification"
  139. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death
  140. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release
  141. Guide to Receptors and Channels, 2nd edition (2007 Revision)
  142. Cannabinoids and PPARα signalling
  143. Guide to Receptors and Channels, 2nd edition
  144. Effects of the A2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo
  145. Flavonoids as antagonists at A1 adenosine receptors
  146. Novel phomactin analogues as PAF receptor ligands
  147. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening
  148. Guide to Receptors and Channels, 1st Edition (2005 revision)
  149. Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106
  150. [3H]ZM241385—an antagonist radioligand for adenosine A2A receptors in rat brain
  151. A1and A2adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig
  152. A1adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig
  153. An endogenous A2Badenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells
  154. An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant
  155. Purines '96
  156. DHPMP: a novel group I specific metabotropic glutamate receptor agonist
  157. Subtypes of metabotropic excitatory amino acid receptor distinguished by stereoisomers of the rigid glutamate analogue, 1-aminocyclopentane-1,3-dicar☐ylate
  158. Endogenous Adenosine Regulates the Apparent Efficacy of 1-Aminocyclopentyl-1S,3R-Dicarboxylate Inhibition of Forskolin-Stimulated Cyclic AMP Accumulation in Rat Cerebral Cortical Slices
  159. Activation of a metabotropic excitatory amino acid receptor potentiates A2b adenosine receptor-stimulated cyclic AMP accumulation
  160. Qualitative differences in [Ca2+]i increases and InsP3 generation following stimulation of N1E-115 cells with micromolar and millimolar ATP
  161. Excitatory Amino Acid-Induced Phosphoinositide Turnover in Guinea Pig Cerebral Cortical Slices: Selective Enhancement by Spermine of the Response to DL-1-Aminocyclopentane- trans-1, 3-Dicarboxylate
  162. Inhibition of Forskolin-Stimulated Cyclic AMP Formation by 1-Aminocyclopentane-trans-1,3-Dicarboxylate in Guinea-Pig Cerebral Cortical Slices
  163. Do polyamines regulate the NMDA inhibition of muscarinic receptor-induced phosphoinositide turnover in guinea pig brain?
  164. Adenosine Receptor Modulation of Inositol Phospholipid Turnover in the Central Nervous System
  165. Differential effects of elevated calcium ion concentrations on inositol phospholipid responses in mouse and rat cerebral cortical slices